Scholarlink

Purpose <p>Humanin is a mitochondria-derived peptide (MDP) secreted in response to oxidative stress and linked to diverse cellular processes including inflammation and insulin resistance (IR). In a PCOS rat model, humanin has been shown to be downregulated in polycystic ovaries, and exogenous humanin supplementation has attenuated IR and ovarian morphological abnormalities. We aimed to investigate the role of humanin in the pathophysiology of PCOS by comparing serum and skeletal muscle tissue profiles in women with PCOS and healthy women.</p> Methods <p>Forty women with PCOS [(mean ± SD) age:21.8 ± 2.3 years, BMI:25.0 ± 4.8&#xa0;kg/m2] and 40 age- and BMI-matched healthy controls were included. Anthropometric, hormonal, biochemical measurements and body composition analyses were carried out in all participants. Vastus lateralis muscle biopsies were analyzed for humanin expression from a subset of patients and controls who consented to the procedure.</p> Results <p>Serum humanin levels were significantly lower in the PCOS group than those in controls [Median (IQR):474.9 (313.0–633.5) pg/mL vs. 672.3 (481.7-764.6) pg/mL <i>p</i> &lt; 0.001)]. Western blot analysis showed no significant difference in skeletal muscle humanin levels between PCOS and control groups (<i>p</i> = 0.71). Serum humanin showed negative correlations with testosterone, 2&#xa0;h insulin during OGTT, total cholesterol, LDL, and triglycerides.</p> Conclusion <p>Serum humanin levels are decreased in PCOS suggesting mitochondrial dysfunction that appears to be associated with androgen excess, IR and lipids. Reduction of circulating humanin is unlikely to be linked to an alteration of this MDP in the skeletal muscle which constitutes the majority of the mitochondrial reserve in the body.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Assessment of mitochondrial peptide humanin in women with polycystic ovary syndrome: serum and skeletal muscle profile

  • 期刊论文

  • 发表日期：

    2025年11月4日

查看全文
  • Irem Sonmezoglu Kutuk,
  • Senay Akin,
  • Haydar Demirel,
  • Sezcan Mumusoglu,
  • Turkmen Ciftci,
  • Bulent Okan Yildiz

摘要

Purpose

Humanin is a mitochondria-derived peptide (MDP) secreted in response to oxidative stress and linked to diverse cellular processes including inflammation and insulin resistance (IR). In a PCOS rat model, humanin has been shown to be downregulated in polycystic ovaries, and exogenous humanin supplementation has attenuated IR and ovarian morphological abnormalities. We aimed to investigate the role of humanin in the pathophysiology of PCOS by comparing serum and skeletal muscle tissue profiles in women with PCOS and healthy women.

Methods

Forty women with PCOS [(mean ± SD) age:21.8 ± 2.3 years, BMI:25.0 ± 4.8 kg/m2] and 40 age- and BMI-matched healthy controls were included. Anthropometric, hormonal, biochemical measurements and body composition analyses were carried out in all participants. Vastus lateralis muscle biopsies were analyzed for humanin expression from a subset of patients and controls who consented to the procedure.

Results

Serum humanin levels were significantly lower in the PCOS group than those in controls [Median (IQR):474.9 (313.0–633.5) pg/mL vs. 672.3 (481.7-764.6) pg/mL p < 0.001)]. Western blot analysis showed no significant difference in skeletal muscle humanin levels between PCOS and control groups (p = 0.71). Serum humanin showed negative correlations with testosterone, 2 h insulin during OGTT, total cholesterol, LDL, and triglycerides.

Conclusion

Serum humanin levels are decreased in PCOS suggesting mitochondrial dysfunction that appears to be associated with androgen excess, IR and lipids. Reduction of circulating humanin is unlikely to be linked to an alteration of this MDP in the skeletal muscle which constitutes the majority of the mitochondrial reserve in the body.